Literature DB >> 33716525

Is There an Association Between Nasal Polyposis and ADAMTS Genes Expressions?

Cigdem Yuce Kahraman1, Arzu Tatar2, Muzaffer Keles3, Zeynep Ipek Ocak4, Abdulgani Tatar1.   

Abstract

OBJECTIVE: Nasal polyposis (NP) is an inflammatory chronic disease in which polyps are located in the nose or paranasal sinuses. A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) genes have roles in vascular biology, inflammation, tissue morphogenesis, and pathophysiological remodeling. Therefore, some members of the ADAMTS gene family may contribute to pathogenesis of NPs. This study aimed to detect the potential relation between NP and the expression levels of ADAMTS 5, 8, and 9 genes.
MATERIALS AND METHODS: This study consisted of nasal polyp tissues from 34 patients in whom nasal polyps had been diagnosed clinically, and healthy nasal mucosal tissues from 14 controls. RNA was isolated from the nasal polyps and normal nasal mucosal tissue in each subject. The expression levels of ADAMTS 5, 8, and 9 genes in the patients and controls were detected by quantitative real-time reverse transcriptase polymerase chain reaction (qRT-PCR) method.
RESULTS: The expression levels of ADAMTS 5 and 9 genes were significantly decreased in NP tissues. In contrast, the expression levels of ADAMTS 8 genes were also decreased in NP tissues, but they were not significantly different from those in the normal nasal tissues.
CONCLUSION: An association was detected between the expression levels of ADAMTS genes and NP. ADAMTS 5 and 9 genes may have an effect on the formation of NP. ©Copyright 2021 by the Atatürk University School of Medicine - Available online at www.eurasianjmed.com.

Entities:  

Keywords:  ADAMTS-5; ADAMTS-8; ADAMTS-9; Nasal polyps

Year:  2021        PMID: 33716525      PMCID: PMC7929586          DOI: 10.5152/eurasianjmed.2021.20006

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  17 in total

1.  Angiogenesis in chronic rhinosinusitis with nasal polyps and in antrochoanal polyps.

Authors:  Nir Hirshoren; Tzahi Neuman; Menachem Gross; Ron Eliashar
Journal:  Inflamm Res       Date:  2010-10-23       Impact factor: 4.575

2.  ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells.

Authors:  Bon-Hun Koo; David M Coe; Laura J Dixon; Robert P T Somerville; Courtney M Nelson; Lauren W Wang; Mary Elizabeth Young; Daniel J Lindner; Suneel S Apte
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

Review 3.  Epidemiology of nasal polyps.

Authors:  G A Settipane
Journal:  Allergy Asthma Proc       Date:  1996 Sep-Oct       Impact factor: 2.587

Review 4.  Nasal polyposis: an update: editorial review.

Authors:  Ruby Pawankar
Journal:  Curr Opin Allergy Clin Immunol       Date:  2003-02

Review 5.  Expression of Vascular Endothelial Growth Factor in Nasal Polyp and Chronic Rhinosinusitis.

Authors:  Alireza Azizzadeh Delshad; Mohammadreza Jalali Nadoushan; Ali Davati; Aida Rostami
Journal:  Iran J Pathol       Date:  2016

Review 6.  Pathogenesis of nasal polyposis.

Authors:  K E Hulse; W W Stevens; B K Tan; R P Schleimer
Journal:  Clin Exp Allergy       Date:  2015-02       Impact factor: 5.018

7.  Chronic rhinosinusitis with and without nasal polyps is associated with decreased expression of glucocorticoid-induced leucine zipper.

Authors:  X-H Zhang; X Lu; X-B Long; X-J You; Q-X Gao; Y-H Cui; Z Liu
Journal:  Clin Exp Allergy       Date:  2009-03-02       Impact factor: 5.018

Review 8.  The molecular biology of nasal polyposis.

Authors:  J M Bernstein
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.919

Review 9.  The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family.

Authors:  Richard Kelwick; Ines Desanlis; Grant N Wheeler; Dylan R Edwards
Journal:  Genome Biol       Date:  2015-05-30       Impact factor: 13.583

10.  Emerging Roles of ADAMTSs in Angiogenesis and Cancer.

Authors:  Saran Kumar; Nithya Rao; Ruowen Ge
Journal:  Cancers (Basel)       Date:  2012-11-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.